alexa Soluble Guanylate Cyclase: An Emerging Therapeutic Target In Primary Open Angle Glaucoma
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

4th International Conference on Clinical & Experimental Ophthalmology
July 14-16, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Emmanuel Buys
ScientificTracks Abstracts: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570.S1.017
Abstract
Primary open angle glaucoma (POAG) is a leading cause of blindness worldwide. The molecular signaling involved remains largely unknown. Currently, there is no cure for POAG, available therapies offer incomplete protection, and the disease often goes undetected until irreparable damage has been done. Together, these considerations highlight the need for novel therapeutic approaches, drug targets, and biomarkers. We recently reported that female mice lacking the α1 subunit of the nitric oxide (NO) receptor soluble guanylate cyclase (sGCα1 -/- mice) develop POAG, characterized by age-related RNFL thinning, loss of retinal ganglion cells, and optic neuropathy in the setting of an open iridocorneal angle. The optic neuropathy associated with sGCα1-deficiency was accompanied by modestly increased intraocular pressure and retinal vascular dysfunction. In addition, we identified a variant in the GUCY1A3/ GUCY1B3 locus (encoding the α 1 and β 1 subunit genes of sGC, arranged in tandem) that was associated with POAG. Together, these data provide new insights into the pathogenesis and genetics of POAG and identify sGC as a potential therapeutic target for POAG.
Biography
Emmanuel Buys obtained his Ph.D. from the Department of Molecular Biology, Gent University and Flanders Institute of Biotechnology. He is currently an Assistant Professor in Anesthesia at the Massachusetts General Hospital where he studies the role of nitric oxide-cGMP signaling in systemic hypertension (funded by the American heart Association) and primary open angle glaucoma (Funded by an NIH-R01). He has co-authored 46 manuscripts since 2006.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords